Impact of Robotic Antineoplastic Preparation on Safety, Workflow, and Costs

Abstract

Although robotically prepared antineoplastic and adjuvant medications did not reduce serious medication errors, both staff safety and accuracy of medication preparation were improved significantly. Future studies are necessary to address the overall cost effectiveness of these robotic implementations.